Tenaya Therapeutics Inc (TNYA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $79.59M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tenaya Therapeutics Inc (TNYA) Earnings: Report Dates and Results
Tenaya Therapeutics (TNYA) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Tenaya Therapeutics reported EPS of -$0.08, above the -$0.10 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TNYA has an expected report date of Mar 4, 2027.
Earnings History
Of the 22 quarters below that had an estimate, TNYA beat 14, missed 7 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2021, when EPS landed 84.94% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.08 | -$0.10 | -$0.10 - -$0.09 | +20.00% | Beat | N/A | 4 | 0 up, 3 down | Nov 4, 2026 | $1.70M |
| Jun 30, 2026 | -$0.09 | -$0.08 | -$0.14 - -$0.04 | -12.50% | Miss | N/A | 6 | 1 up, 0 down | Aug 5, 2026 | $1.11M |
| Mar 31, 2026 | -$0.09 | -$0.09 | -$0.14 - -$0.05 | 0.00% | In line | N/A | 6 | 1 up, 0 down | May 6, 2026 | $225000 |
| Dec 31, 2025 | -$0.12 | -$0.14 | -$0.17 - -$0.10 | +12.73% | Beat | N/A | 8 | 4 up, 0 down | Mar 11, 2026 | N/A |
| Sep 30, 2025 | -$0.12 | -$0.15 | -$0.18 - -$0.10 | +20.00% | Beat | N/A | 8 | 5 up, 0 down | Nov 10, 2025 | N/A |
| Jun 30, 2025 | -$0.14 | -$0.19 | -$0.26 - -$0.11 | +26.32% | Beat | N/A | 8 | 1 up, 3 down | Aug 6, 2025 | N/A |
| Mar 31, 2025 | -$0.24 | -$0.20 | -$0.31 - -$0.14 | -20.00% | Miss | N/A | 6 | 3 up, 0 down | May 7, 2025 | N/A |
| Dec 31, 2024 | -$0.28 | -$0.31 | -$0.35 - -$0.28 | +9.68% | Beat | N/A | 8 | 1 up, 0 down | Mar 10, 2025 | N/A |
| Sep 30, 2024 | -$0.30 | -$0.37 | -$0.44 - -$0.33 | +18.92% | Beat | N/A | 8 | 0 up, 0 down | Nov 6, 2024 | N/A |
| Jun 30, 2024 | -$0.34 | -$0.39 | -$0.49 - -$0.28 | +12.82% | Beat | N/A | 9 | 0 up, 0 down | Aug 8, 2024 | N/A |
| Mar 31, 2024 | -$0.40 | -$0.42 | -$0.45 - -$0.40 | +4.76% | Beat | N/A | 7 | 0 up, 0 down | May 14, 2024 | N/A |
| Dec 31, 2023 | -$0.40 | -$0.44 | -$0.50 - -$0.40 | +9.09% | Beat | N/A | 8 | 0 up, 0 down | Mar 18, 2024 | $17.66M |
| Sep 30, 2023 | -$0.39 | -$0.48 | -$0.57 - -$0.40 | +18.75% | Beat | N/A | 7 | 0 up, 0 down | Nov 8, 2023 | N/A |
| Jun 30, 2023 | -$0.45 | -$0.51 | -$0.54 - -$0.46 | +11.76% | Beat | N/A | 6 | 0 up, 0 down | Aug 9, 2023 | N/A |
| Mar 31, 2023 | -$0.43 | -$0.55 | -$0.72 - -$0.45 | +21.82% | Beat | N/A | 6 | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$0.61 | -$0.65 | -$0.78 - -$0.51 | +6.15% | Beat | N/A | 6 | 0 up, 0 down | Mar 8, 2023 | N/A |
| Sep 30, 2022 | -$0.74 | -$0.68 | -$0.75 - -$0.55 | -8.82% | Miss | N/A | 6 | 0 up, 0 down | Nov 10, 2022 | N/A |
| Jun 30, 2022 | -$0.69 | -$0.74 | N/A | +6.76% | Beat | N/A | N/A | 0 up, 0 down | Aug 10, 2022 | N/A |
| Mar 31, 2022 | -$0.75 | -$0.64 | -$0.69 - -$0.57 | -17.19% | Miss | N/A | 4 | 0 up, 0 down | May 11, 2022 | N/A |
| Dec 31, 2021 | -$0.63 | -$0.60 | -$0.83 - -$0.40 | -5.00% | Miss | N/A | 4 | 0 up, 0 down | Mar 23, 2022 | N/A |
| Sep 30, 2021 | -$0.68 | -$0.48 | -$1.36 - -$0.36 | -41.67% | Miss | N/A | 4 | 1 up, 1 down | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$13.26 | -$7.17 | -$13.62 - -$0.73 | -84.94% | Miss | N/A | 2 | N/A | Jul 30, 2021 | N/A |
| Mar 31, 2021 | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 2, 2021 | N/A |
| Dec 31, 2020 | -$11.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | N/A |
| Dec 31, 2019 | -$10.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.62, after -$1.32 the year before. It was -$10.15 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.62 | N/A |
| Dec 31, 2024 | -$1.32 | N/A |
| Dec 31, 2023 | -$1.67 | N/A |
| Dec 31, 2022 | -$2.79 | N/A |
| Dec 31, 2021 | -$14.97 | N/A |
| Dec 31, 2020 | -$11.93 | N/A |
| Dec 31, 2019 | -$10.15 | N/A |
Frequently Asked Questions About TNYA
When is Tenaya Therapeutics's next earnings date?
Tenaya Therapeutics's next earnings report is expected for Mar 4, 2027.
Did TNYA beat earnings estimates last quarter?
Yes. Tenaya Therapeutics reported EPS of -$0.08 for the quarter ended Sep 30, 2026, above the -$0.10 estimate, a 20.00% surprise.
What EPS do analysts expect from TNYA next quarter?
The consensus EPS estimate for Tenaya Therapeutics for the quarter ending Dec 31, 2026 is -$0.09 from 8 analysts, with estimates from -$0.10 to -$0.07.
How often does TNYA beat earnings estimates?
Tenaya Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +7.03%.
TNYA pages: Overview, Earnings, Forecast, Financials, Competitors